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The paraventricular nucleus of the thalamus (PVT) sends a very dense projection to the
nucleus accumbens. This area of the striatum plays a key role in motivation and recent
experimental evidence indicates that the PVT may have a similar function. It is well known
that a dopaminergic projection from the ventral tegmental area (VTA) to the nucleus
accumbens is a key regulator of motivation and reward-related behavior. Dopamine (DA)
fibers have also been localized in the PVT but the source of these fibers in the rat
has not been unequivocally identified. The present study was done to re-examine this
question. Small iontophoretic injections of cholera toxin B (CTb) were made in the PVT
to retrogradely label tyrosine hydroxylase (TH) neurons. Neurons that were double-labeled
for TH/CTb were found scattered in DA cell groups of the hypothalamus (ventrorostral
A10, A11, A13, A15 DA cell groups) and the midbrain (dorsocaudal A10 embedded in the
periaqueductal gray). In contrast, double-labeled neurons were absent in the retrorubral
field (A8), substantia nigra (A9) and VTA (A10) of the midbrain. We conclude that DA fibers
in the PVT do not originate from VTA but from a heterogeneous population of DA neurons
located in the hypothalamus and periaqueductal gray.
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INTRODUCTION
The paraventricular nucleus of the thalamus (PVT) is a member
of a group of midline and intralaminar thalamic nuclei that are
believed to be involved in cognition, attention and arousal (Groe-
newegen and Berendse, 1994; Van der Werf et al., 2002). Each
member of this group has circumscribed projections to unique
regions of the cerebral cortex and the striatum. This anatomical
arrangement has led to the view that different members of the
midline and intralaminar nuclei are part of functionally distinct
circuits with specialized functions (Groenewegen and Berendse,
1994; Van der Werf et al., 2002). The PVT is of special interest
because of its dense projection to the nucleus accumbens of the
ventral striatum (Li and Kirouac, 2008; Vertes and Hoover, 2008),
Abbreviations: 3V, 3rd ventricle; A8, retrorubral dopamine group; A9, sub-
stantia nigra; A10, ventral tegmental area; A10dc, periaqueductal gray matter;
A10vr, A10 ventrorostral dopamine group; A11, A11 dopamine group; A13,
A13 dopamine group; Aq, aqueduct; CM, central medial thalamic nucleus;
cp, cerebral peduncle; DA, dopamine; f, fornix; fr, fasciculus retroflexus;
Hb, habenular; IMD, intermediodorsal thalamic nucleus; MD, mediodorsal
thalamic nucleus; ml, medial lemniscus; mt, mammillothalamic tract; opt,
optic tract; PT, paratenial thalamic nucleus; PVT, paraventricular thalamic
nucleus; Rt, reticular thalamic nucleus; sm, stria medullaris of the thalamus;
VTA, ventral tegmental area; xscp, decussation sup cereballar ped; ZI, zona
incerta.
an area of the brain closely linked to the regulation of reward
and motivation (Nicola, 2007; Humphries and Prescott, 2010).
In addition, the PVT projects to all the major sources of inputs
to the nucleus accumbens including the medial prefrontal cortex
(ventral prelimbic and infralimbic cortices), ventral subiculum of
the hippocampus, and the basolateral nucleus of the amygdala
(Groenewegen et al., 1987; Berendse and Groenewegen, 1990;
Berendse et al., 1992; Brog et al., 1993; Wright and Groenewegen,
1995; Wright et al., 1996).
Recent experimental evidence supports a role for the PVT in
drug seeking and reward-related behaviors (Martin-Fardon and
Boutrel, 2012; James and Dayas, 2013; Matzeu et al., 2014). For
instance, an increase in cFos has been observed in the PVT follow-
ing the re-exposure of rodents to the context or cues associated
with cocaine administrations (Brown et al., 1992; Franklin and
Druhan, 2000; James et al., 2011). Inactivation of the PVT was also
reported to attenuate cocaine-prime induced reinstatement of
self-administration as well as cocaine induced conditioned place
preference (James et al., 2010; Browning et al., 2014). Similarly,
an increase in cFos was found in the PVT following context-
and cue-induced reinstatement of alcohol seeking in rodents
(Wedzony et al., 2003; Dayas et al., 2008; Perry and Mcnally,
2013) while inactivation of the PVT was reported to attenuate
context-induced reinstatement of ethanol (Hamlin et al., 2009;
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Marchant et al., 2010). Finally, evidence in support of a role
for the PVT in food reward is provided by studies showing an
increase in cFos in the PVT following exposure to cues that
predict a sucrose reward (Igelstrom et al., 2010; Flagel et al.,
2011).
Dopamine (DA) neurons in the ventral tegmental area (VTA)
and their projections to the nucleus accumbens have been
implicated in reward and motivation (Pennartz et al., 1994;
Ikemoto and Panksepp, 1999; Schultz, 2000; Salamone et al.,
2005; Ikemoto, 2007). The PVT has also been shown to contain
fibers that stain for tyrosine hydroxylase (TH), the rate limiting
enzyme involves in the synthesis of DA (Takada et al., 1990;
Otake and Ruggiero, 1995). In addition, the PVT contains fibers
immunopositive for DA as well as the DA transporter indicating
that some of the TH fibers in that area of the thalamus are
dopaminergic fibers (Groenewegen, 1988; García-Cabezas et al.,
2009). Indeed, the PVT was reported to contain a more notable
plexus of immunopositive DA fibers than other dorsal midline
thalamic nuclei (Groenewegen, 1988). Consequently, it is possible
that the PVT is part of the neural circuitry that mediates DA’s
motivational functions (VTA-PVT-nucleus accumbens). How-
ever, the two studies that have examined the source of DA fibers
in the PVT in the rat have come to different conclusions with one
study finding evidence that the VTA provided the input (Takada
et al., 1990) while the other reporting that the hypothalamus was
the source (Otake and Ruggiero, 1995). Part of this discrepancy
may be due to differences in the placement of retrograde tracers
in the midline thalamus. The interpretation of these two studies
is also limited by the fact that the location of the injections is not
clearly shown.
It is important that the sources of DA fibers in the PVT
be unequivocally identified to better understand the potential
involvement of the PVT in DA-mediated behaviors. In this study,
iontophoretic injections of the retrograde tracer cholera toxin B
(CTb) were made in the anterior and posterior segments of
the PVT (referred to as the aPVT and pPVT, respectively). The
location of CTb and TH double-labeled cells were assessed in
areas of the brain known to contain DA neurons.
MATERIALS AND METHODS
ANIMALS
Male Sprague–Dawley rats weighing 210± 10 g (n = 8; University
of Manitoba vivarium) were used for this study. Animals were
housed on a 12/12-h light/dark cycle with food and water freely
available. The experimental procedures were in compliance with
the Canadian Council on Animal Care and the experimental
protocol was approved by Research Ethics Review Board of the
University of Manitoba.
RETROGRADE TRACING EXPERIMENT
Rats were anesthetized with a mixture of ketamine (Ketalean
Hydrochloride 100 mg/ml, 100 mg/kg, i.p.) and xylazine
(Rompun 20 mg/ml, 10 mg/kg, i.p.) and given supplementary
doses if necessary. Animals were placed in a Stoelting stereotaxic
frame and a hand drill was used to expose the brain surface
above the target sites. Iontophoretic injections of 0.5% CTb
(List Biologicals, Campbell, CA, USA), which was dissolved in
0.01 M phosphate buffer (PB; pH 7.4), were done by applying
a positive current of 1.0–2.5 µA (200 ms pulses at 2 Hz for
15 min) through a chlorinated silver wire placed in a glass pipette
(approximately 7 µm diameter tip). The coordinates used for
injecting CTb were as follows: aPVT at 1.5 mm posterior, 1.0 mm
lateral, 5.0 mm ventral, 10◦ angle toward the middle; and pPVT
at 3.0 mm posterior, 0.7 mm lateral, 5.0 mm ventral, 10◦ angle
toward the middle (all coordinates are relative to bregma and
the dural surface of the brain with the incisor bar at 3.3 mm
below intra-aural line). After the scalp incisions were sutured,
rats were returned to their home cages for recovery. The analgesic
Carprofen (5 mg/kg, s.c.) was given after surgery and 12 h later.
After a 10- to 12-day postoperative survival, rats were deeply
anesthetized with 10% chloral hydrate and transcardially perfused
with 150 ml heparinized saline followed by 400–500 ml ice-
cold 4% paraformaldehyde in 0.1 M PB (pH 7.4). The brains
were removed, post-fixed in the same fixative for 1–2 h, and
cryoprotected in graded sucrose concentrations (10 and 20% w/v)
over 2 days at 4◦C. Sections of the brain were taken at 50 µm
and placed in 0.1 M phosphate-buffered saline (PBS; pH 7.4)
with 0.1% sodium azide and stored at 4◦C until the time of the
immunoreaction.
IMMUNOHISTOCHEMISTRY
All immunohistochemical reactions were carried out at room
temperature on free-floating sections. Primary and secondary
antibodies were diluted in blocking solution containing 0.1%
sodium azide, 5% normal donkey serum, and 0.3% Triton X-100
in PBS. Every 4th sections were pre-incubated in the blocking
solution for 1 h at room temperature, and then transferred
to a cocktail of primary antibodies containing goat anti-CTb
(1:10,000; List Biologicals; cat. #703, lot 7032H) and monoclonal
mouse anti-tyrosine hydroxylase (TH; 1:100,000; Sigma; cat.
#T2928; clone TH-16) and incubated overnight. After 3 rinses,
sections were transferred into a biotinylated donkey anti-goat
antibody solution (1:500; Jackson Immunoresearch, West Grove,
PA, USA) for 1 h. Sections were rinsed again and then exposed
to an avidin–biotin complex (Elite ABC Kit; Vector Laboratories,
Burlingame, CA, USA) for 60 min. After a few more rinses, the
tissue was reacted for 3–5 min with diaminobenzidine (DAB)
with nickel intensification (Vector DAB Kit) to produce black
CTb labeling. The brain sections were then rinsed in PBS and
incubated in biotinylated donkey anti-mouse antiserum (1:500;
Jackson Immunoresearch) for 1 h. Sections were rinsed and
incubated in ABC for 60 min, rinsed, and reacted for 1–2 min
with DAB without nickel intensification to produce brown TH
cell labeling. The DAB reaction was terminated by rinsing in PBS
before the sections were mounted onto gelatin coated slides and
coverslipped.
The antibodies used for these experiments have been pre-
viously characterized. The CTb antibody does not bind to any
endogenous epitopes in the rat brain (Luppi et al., 1990).
The monoclonal TH antibody was produced from the TH-16
hybridoma and purified rat TH was used as the immunogen
to produce this antibody. This TH antibody recognizes a spe-
cific epitope present on the N-terminal region of rodent TH
(technical information provided by manufacturer). Furthermore,
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this antibody produced the same staining pattern in the rat brain
as previously reported (Lindvall et al., 1983; Hökfelt et al., 1984)
and negative controls (leaving out the primary antibody) were
used to establish specificity of the TH staining.
ANALYSIS
Brain sections were examined with an Olympus BX51 microscope
and only the cases with injections that resulted in a dense core
of CTb confined to the PVT were used for the present study.
Since the purpose of the present study was to examine the source
of DA innervation to the PVT, only areas of the hypothalamus
and brainstem containing the DA cell groups were examined
for the presence of TH/CTb double-labeled neurons. Neurons
expressing DA form a continuum that extends from the peri-
aqueductal gray to the preoptic area of the hypothalamus. This
continuum has been subdivided into different groups based on
earlier classification (Dahlstroem and Fuxe, 1964; Léger et al.,
2010): A8 (retrorubral field of the caudal mesencephalic reticular
formation); A9 (substantia nigra pars compacta and lateralis);
A10 (ventral tegmental area); A10 dorsocaudal (A10dc, peri-
aqueductal gray matter); A10 ventrorostral (A10vr, cells ante-
rior to the VTA in the supramammillary regon); A11 (from
the rostral portion of the periaqueductal gray to the poste-
rior hypothalamus adjacent to the mammillothalamic tract);
A12 (arcuate nucleus); A13 (zona incerta region); A14 (along
the third ventricle in the rostral hypothalamus including the
posterior part of the paraventricular hypothalamamic nucleus);
and the A15 (anterior hypothalamus region above the optic
chiasm/suproptic nucleus and ventral to the anterior commis-
sure). Every section was examined at high magnification for the
presence of CTb granules in TH positive neurons. A figure of
a representative case showing TH and TH/CTb-double labeled
neurons was produced using Adobe Illustrator (CS4) by digitally
superimposing photographed images of the areas in question
with digital drawings modified from a stereotaxic atlas (Paxinos
and Watson, 2009). Examples of CTb- and TH-positive neu-
rons were photographed using a digital camera (Spot RT Slicer;
Diagnostic Instruments, Sterling Heights, MI) mounted on the
microscope. The calibration bars were inserted with the Spot
software (version 3.2; Diagnostic Instruments) and images were
transferred to Adobe Photoshop (CS4) to optimize light and
contrast levels.
RESULTS
INJECTIONS
Data on the sources of DA fibers to the PVT were obtained
from cases that had CTb injections that were almost entirely
restricted to either the aPVT (n = 4; Figure 1A) or pPVT (n
= 4; Figure 1B). Figure 2 shows the location of the dense
CTb core of each injection in relation to the PVT and other
midline thalamic nuclei. In most cases, the dense core (area
likely to result in retrograde transport) covered a large part of
the PVT with a very minor involvement of the mediodorsal,
paratenial, centromedial, or intermediodorsal nuclei. The PVT
extends the entire length of the thalamus and the extent of the
injection core was restricted to only a portion of the aPVT or
pPVT. This may produce a gross underestimation of DA neurons
FIGURE 1 | Examples of injection sites. Digital image examples of cholera
toxin B injection in the anterior (A) and posterior (B) aspects of the
paraventricular nucleus of the thalamus. For abbreviations, see list.
likely to supply afferents to the PVT. The approach of using
small injections was necessary since other tracing studies have
shown that the mediodorsal nucleus and habenular complex
located immediately adjacent to the PVT are innervated by DA
neurons in the VTA (Groenewegen, 1988; Gruber et al., 2007).
Large injections of CTb in the dorsal thalamus could have led
to incorrect conclusions about the sources of DA afferents to
the PVT.
PATTERN OF RETROGRADE LABELING
A large number of CTb-labeled neurons were found in many
regions of the hypothalamus as previously reported (Otake
and Ruggiero, 1995; Li and Kirouac, 2012). Figures 3, 4 show
the location of CTb- and TH-labeled neurons in areas of
the hypothalamus and midbrain, respectively, following the
analysis of an injection of CTb in the pPVT. Based on the
large number of CTb-labeled cells in the hypothalamus, it
is clear that the injection sites used for the present paper
were adequate to examine the sources of the DA fibers in
the PVT. Consistent with previous papers, the periaqueduc-
tal gray, dorsomedial nucleus of the hypothalamus, and the
reticular nucleus of the thalamus were found to be the major
sources of inputs to the pPVT (Otake and Ruggiero, 1995;
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FIGURE 2 | Injection sites. Schematic representation of cholera toxin B injections in the anterior (A) and posterior (B) aspects of the paraventricular nucleus of
the thalamus. Numbers on the bottom of each drawing represent the distance from bregma. For abbreviations, see list.
Li and Kirouac, 2012). The distribution of TH-labeled neu-
rons was consistent with previous descriptions of the DA cell
groups in the hypothalamus and midbrain (Dahlstroem and
Fuxe, 1964; Léger et al., 2010). After close examination of
all the cases, we found that the majority of TH/CTb double-
labeled neurons were located in the A15 (Figures 3A–C), A13
(Figures 3E,F, 5A–C), and A11 cell groups (Figures 3G,H,
4A, 5D–G). In addition, TH/CTb double-labeled neurons were
found scattered in the zona incerta (Figures 3E,F), A12 group
(Figure 3E), perifornical hypothalamus (Figures 3D–F), A10vr
area (Figures 3H, 4A, 5H–J) and periaqueductal gray (A10dc;
Figure 4D). Of note, double-labeled neurons were not found
in the VTA (A10), substantia nigra (A9), and the retrorubral
field (A8) as shown in Figures 4B,C. Consistent with the fact
that the CTb injections involved predominately one side of the
PVT, in all cases double-labeled neurons were found bilaterally
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FIGURE 3 | Retrograde labeling in the hypothalamus. The rostrocaudal
sequence of sections are labeled from (A–H). Drawings of coronal sections
with major dopamine cell groups illustrating cells that were immunopositive
for tyrosine hydroxylase (TH; red) and cholera toxin B (CTb; green) after an
injection of CTb into the posterior part of the paraventricular nucleus of the
thalamus. The location of TH/CTb double-labeled neurons are shown as black
stars. Numbers on the bottom right of each drawing represent the distance
from bregma. For abbreviations, see list.
with an ipsilateral predominance in both the hypothalamus and
midbrain (Figures 3, 4). Although the aPVT injections resulted
in fewer double-labeled neurons, there were no qualitative
differences on the pattern of TH/CTb double-labeled neurons
between injections in the aPVT and pPVT. Attempts to quantify
the proportion of TH-positive neurons that were CTb-positive
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FIGURE 4 | Retrograde labeling in midbrain. The rostrocaudal sequence of
sections are labeled from (A–D). Drawings of coronal sections with major
dopamine cell groups illustrating cells that were immunopositive for tyrosine
hydroxylase (TH; red) and cholera toxin B (CTb; green) after an injection of
CTb into the posterior part of the paraventricular nucleus of the thalamus. The
location of TH/CTb double-labeled neurons are shown as black stars.
Numbers on the bottom right of each drawing represent the distance from
bregma. For abbreviations, see list.
were abandoned because these numbers were low and vari-
able across different cases. Nonetheless, it is possible that some
double-labeled neurons may have been missed because the dense
CTb reaction product found in some neurons may have obscured
the TH staining in the same neurons.
There were not many usable “off-target” injection sites in the
present study. In fact, the technical issue most often encoun-
tered was not of making injections outside the PVT but rather
that the tracer did not diffuse out of the micropipette suffi-
ciently to yield an injection site capable of producing retrograde
labeling. A couple of injection sites in the paratenial nucleus
immediately adjacent to the aPVT produced a large number
of retrogradely labeled neurons in the prefrontal cortex but no
labeling in the hypothalamus or the midbrain. It should also
be pointed out that there was no evidence of double-labeled
neurons in the VTA in the cases in which the CTb injection
involved the medial most part of the mediodorsal nucleus. This
indicates that the PVT and other nuclei immediately adjacent
to the PVT do not receive any appreciable innervation from
DA neurons in the VTA. Finally, the absence of double-labeled
neurons in the VTA, which is known to provide a robust DA
innervation of the habenula by way of the fasciculus retroflexus
(Gruber et al., 2007), provides further reassurance that the
labeling observed was not due to diffusion of CTb outside
the PVT or from uptake by damaged fibers traveling through
the PVT.
DISCUSSION
The main finding of the present study is that neurons that are
located in the hypothalamus and periaqueductal gray provide
the DA fibers to the PVT. Most of the TH/CTb double-labeled
neurons were found in the A10vr, A11, A13, A15 DA cell groups
of the hypothalamus and A10dc of the periaqueductal gray. In
contrast, no evidence was found that the PVT receives projections
from DA neurons in the ventral tegmental area (A10, excluding
the A10vr and A10dc), substantia nigra (A9), and the retrorubral
field (A8). While there are clear differences between rodents
and primates in the distribution and density of DA fibers in
the thalamus (García-Cabezas et al., 2009), the findings in the
present study show that the origin of DA fibers in the dorsal
midline thalamus is the same between these two species (Sánchez-
González et al., 2005).
Our findings along with the results of other tracing studies
in the rat and primate are in stark contrast with another study
reporting numerous double-labeled TH neurons in the VTA and
retrorubral field following injections of the retrograde tracer
Fluorogold in the PVT (Takada et al., 1990). It is likely that
the false positives observed by the Takada et al. study may have
occurred because Fluorogold was taken up by damaged DA fibers
passing through the dorsal midline thalamus on their way to
the habenular complex (Gruber et al., 2007). Labeling of fibers
of passage is especially problematic when tracers are applied
using pressure injections or when using fluorescent tracers like
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FIGURE 5 | Examples of double-labeled neurons. Digital images of the
dopamine group A13 (A), A11 (D) and A10vr (H) showing cholera toxin B
labeled neurons (black) and tyrosine hydroxylase immunopositive neurons
(brown). The double-labeled neurons (arrows) are also shown at higher
magnification for A13 (B,C), A11 (E–G) and A10vr (I–J). For abbreviations, see
list. Scale bars = 100 µm (A, D, H), 10 µm (B,C, E–G, I–J).
Fluorogold (Aschoff and Holländer, 1982; Dado et al., 1990;
Schofield et al., 2007), as was the case with Takada et al. study
(Takada et al., 1990). It is also possible that the misidentification
of a significant DA projection from the VTA to the PVT may
have been the result of large injections of retrograde tracers that
involved parts of the mediodorsal nucleus, which has been shown
to receive DA fibers from the VTA (Groenewegen, 1988). The lack
of evidence for a DA projection from the VTA to the PVT is also
in line with the tracing studies showing an absence of retrogradely
labeled neurons in the VTA following injections of tracers in the
PVT (Cornwall and Phillipson, 1988; Chen and Su, 1990; Li and
Kirouac, 2012). Consequently, we conclude that the majority of
evidence available indicates that the PVT does not receive an
appreciable projection from DA neurons in the VTA.
What is the potential functional significance of DA innerva-
tion of the PVT which originates from neurons scattered in the
hypothalamus? This is a question that can only be speculated
at because of the paucity of information about the function of
these DA neurons. One possibility is that this projection may
be involved in arousal since a subpopulation of DA neurons in
the hypothalamus was shown to be activated in rats that had
explored an open field (A11 group) and after sleep deprivation
(A11 and A13 groups) (Léger et al., 2010). While this has not
been demonstrated, it is possible that the DA cell groups in the
hypothalamus have functions related to DA cells in the VTA.
As such, the release of DA along with other transmitters like
orexins and cocaine- and amphetamine-related peptide (James
et al., 2010; Matzeu et al., 2014) could act on the PVT to mod-
ulate reward and motivated behavior. In addition, the A13 DA
cell group has been shown to project to the central nucleus of
the amygdala and the periaqueductal gray matter (Eaton et al.,
1994; Messanvi et al., 2013), two key areas involved in defensive
behaviors (McNaughton and Corr, 2004). This suggests that the
A13 DA group and the PVT may be part of a network involved
in the modulation of defensive behaviors. Indeed, recent exper-
imental evidence indicates that the PVT plays a role in fear,
anxiety and avoidance. For instance, microinjections of excitatory
neuropeptides called orexins in the PVT of rats were found to
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produce anxiety-like behaviors while blocking of orexin receptors
had anxiolytic effects (Li et al., 2009, 2010a,b; Heydendael et al.,
2011). In addition, microinjections of orexin antagonists in the
PVT were shown to attenuate conditioned place avoidance to
morphine withdrawal (Li et al., 2011) and lesions of the pPVT
were reported to attenuate a conditioned fear response (Li et al.,
2014). Numerous studies have also documented that neurons in
the PVT are activated in animals exposed to a variety of stress-
ful/aversive situations (Beck and Fibiger, 1995; Bhatnagar and
Dallman, 1998; Bubser and Deutch, 1999; Timofeeva and Richard,
2001) and it is possible that DA signaling may be involved
in the activation of the PVT following high levels of arousal.
Finally, the A15 DA group has been shown in some species to
be associated with neuroendocrine functions including seasonal
inhibition of gonadotrophin-releasing hormone (Hileman and
Jackson, 1999; Goodman et al., 2010). Consequently, the A15
cell group may influence the PVT in a way that helps coordinate
arousal levels and behaviors with the hormonal status of an
organism.
It is also interesting to note that the primary DA receptor found
in the PVT is the D3 receptor where the expression of this receptor
is high compared to many areas of the rat (Stanwood et al., 2000;
Haight and Flagel, 2014) and human brain (Rieck et al., 2004).
The D3 receptor is of clinical interest because it has been linked
to the regulation of the cognitive symptoms of schizophrenia
and the motivation to seek drugs in addicted individuals (Gross
et al., 2013; Micheli and Heidbreder, 2013). While the potential
therapeutic effects of the D3 antagonists have been shown to be
mediated by D3 receptors in the nucleus accumbens (Gross et al.,
2013; Micheli and Heidbreder, 2013), it is also possible that some
of these effects could be mediated by D3 receptors in the PVT.
For instance, the PVT has been shown to modulate DA release in
the nucleus accumbens (Jones et al., 1989; Parsons et al., 2007;
Choi et al., 2012) and D3 antagonists could act at the PVT to
down-regulate the enhanced DA release in the nucleus accumbens
associated with schizophrenia and drug seeking. In line with
that hypothesis, lesions of the PVT were shown to attenuate the
conditioned aspects of behavioral sensitization to cocaine possibly
through a D3 mediated mechanism in the PVT (Deutch et al.,
1998; Young and Deutch, 1998). Blocking of D3 receptors has
also been shown to attenuate fear expression in conditioned rats
(Swain et al., 2008) and the PVT represents a potential site for this
effect.
In summary, the present tracing study shows that DA innerva-
tion of the PVT originates from the hypothalamus (A10vr, A11,
A13, A15) and periaqueductal gray (A10dc) and not from the
midbrain’s A8, A9 and A10 DA cell groups. The type of signal
carried by these fibers and functional consequence of DA release
in the PVT are not known but the PVT represents a unique site for
D3 receptor antagonists to exert some of their pharmacological
effects. Future research may identify more specific effects of DA
on PVT mediated behaviors.
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